"Analysis 3 years after the 2013 outbreak of Neisseria meningitidis B at Princeton University in New Jersey has found that the vaccine deployed fell short of expectations.
In 2013, the US Food and Drug Administration (FDA) grant"...
IPOL vaccine is contraindicated in persons with a history of hypersensitivity to any component of the vaccine, including 2-phenoxyethanol, formaldehyde, neomycin, streptomycin, and polymyxin B.
Vaccination of persons with an acute, febrile illness should be deferred until after recovery; however, minor illness, such as mild upper respiratory infection, with or without low grade fever, are not reasons for postponing vaccine administration.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 11/30/2015
Additional Ipol Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.